Med Tech-related technology assessments and clinical guidelines from NICE in February 2020

03

Mar 2020

In February 2020, the National Institute for Health and Care Excellence (NICE) published one new diagnostics guidance (for SepsiTest assay for rapidly identifying bloodstream bacteria and fungi), one new medical technologies guidance (for Episcissors-60 for mediolateral episiotomy) and two Medtech innovation briefings (for Plus Sutures for preventing surgical site infection and National Early Warning Score systems that alert to deteriorating adult patients in hospital).

In February 2019, NICE published one new Diagnostics Guidance for SepsiTest assay for rapidly identifying bloodstream bacteria and fungi, which provides evidence-based recommendations on the SepsiTest assay.  There is currently insufficient evidence to recommend the routine adoption in the NHS of the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi. The test shows promise, and further research to provide robust evidence is encouraged, particularly to demonstrate the value of using the test results in clinical decision‑making.

Medical technologies guidance evaluates new, innovative medical devices, and diagnostics. It looks at medical technologies that deliver treatment, like those implanted during surgical procedures, give greater independence to patients or detect or monitor medical conditions.

In February, NICE published one new Medical Technologies Guidance Episcissors-60 for mediolateral episiotomy covers evidence-based recommendations on Episcissors-60 for mediolateral episiotomy. Episcissors‑60 show promise for mediolateral episiotomy. But there is currently not enough evidence to support the case for routine adoption in the NHS. Research is recommended to address uncertainties about the efficacy and safety of using Episcissors‑60.

MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety, and cost. It does not offer formal guidance, and it, therefore, does not provide any recommendations

Two new Medtech Innovation Briefings for Plus Sutures for preventing surgical site infection (for wound closure in adults and children after surgical procedures) and  National Early Warning Score systems that alert to deteriorating adult patients in hospital (integrated software systems that output the national early warning score for adult patients in hospital) have been published in February.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more